Anglais
French
Joseph KATTAN
أستاذ
Président de comité - Recherche clinique
-
كُلِّية الطِّبّ
كُلِّيّة الصَّيْدَلة
+961 (1) 421 000 joseph.kattan@usj.edu.lb
Joseph Kattan is the Head of the Hematology-Oncology Department and Clinical Research Coordinator at Saint Joseph University (USJ) in Beirut, Lebanon, since 2022.
He previously served as the Head of the Hematology-Oncology Division at Saint Joseph Hospital in Beirut from 1994 to 2014, and subsequently as the Head of the Hematology-Oncology Department at Hôtel-Dieu de France University Hospital in Beirut from 2014 to 2022. Additionally, he was the Director of the Continuing Medical Education Office at the Faculty of Medicine at USJ from 2015 to 2022.
A graduate of medicine in 1986, he completed a specialization in Medical Oncology in 1993 and was appointed Professor of Hematology-Oncology at USJ in 1994.
In 1988, he began five years of advanced training at the Institut Gustave-Roussy in Villejuif, France. His main areas of expertise include urogenital, pulmonary, gastrointestinal, and gynecological tumors, as well as intensified therapy and supportive care. He earned degrees in Oncology (1989), Immunology (1991), and Hematology (1993) from Paris-Sud University.
He is responsible for numerous courses and programs in hematology-oncology at USJ and serves as the principal investigator for multiple regional and international clinical trials. He is the founder of the educational tool Learning Through Debate and the FRON (Regional Oncology Research Competition).
He is a member or former member of editorial boards for journals such as Bulletin du Cancer, Lebanese Medical Journal, Cancer Letter, and the International Journal of Hematology and Oncology. He has authored over 350 publications in international journals on topics including pharmacology, drug development, urogenital and gastrointestinal oncology, and supportive care.
He is affiliated with numerous international and regional scientific societies, including ASCO, ESMO, MASCC, SFC, EHA, SIOG, SLC, and LSMO, and is a founding member of the Cancer Research Group (CRG) Collaborative Group, where he currently serves as Secretary General.
محاور البحث
- Pharmacology
- Drug development
- Urogenital gastrointestinal tumors
- Supportive care
المنشورات والمداخلات
Moujaes E, Fakhoury M, Assi T, … Kattan J
The Therapeutic use of human Albumin in cancer patients’ management
Critical Reviews in Oncology/Hematology, 2017, vol 120, 203-209
Kattan C, Badreddine H, Rassy E, Kourie H, Kattan J
The impact of the coronavirus pandemic on the management of cancer patients in
Lebanon: a single institutional experience
Future Oncology 16(17) (Avril 2020) DOI: 10.2217/fon-2020-0313
Aix SP, Ciuleanu TE, Navarro A, Cousin S, … Kattan J, … Paz-Ares L
Combination lurbinectedin doxorubicin versus physicians choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial
The Lancet Respiratory Medicine 11(1) (October 2022)
DOI: 10.1016/S2213-2600(22)00309-5
Samaha R, Kattan C, Rassy E, Kattan J.
Learning by Debate: Innovative Tool in the Hematology-Oncology Fellowship Program
Journal of Cancer Education (March 2021) DOI:10.1007/s13187-021-02002-5
Chebel R, Labaki C, Farhat M, Kattan J
Safety, efficacy and acceptability of SARS-CoV-2 vaccines in patients with cancer
Future Virology (June 2021) DOI:10.2217/fvl-2021-0072
Moujaess E, Bou Zeid N, Samaha R, …, Kattan J.
Perceptions of the COVID-19 vaccine among patients with cancer: a single-institution survey
Future Oncology 17 (August 2021) DOI:10.2217/fon-2021-0265
Assi T, Kattan J, Nassereddine H, Rassy E,…, Le Cesne A.
Chemotherapy in the management of periosteal osteosarcoma: A narrative review Journal of Bone Oncology 30(7) (Septembre 2021) DOI: 10.1016/j.jbo.2021.100389
Kattan J, Karak F. Farhat F, Abi Gerges D, Mokadem W, …, Nasr F.
Prevalence of Her2 neu status and its clinicopathological association in newly diagnosed gastric cancer patients
BMC Cancer 22(1114) (November 2022) DOI:10.1186/s12885-022-10206-1
Kattan J, Kattan C.
Accommodation with anticancer drug shortage: A Lebanese harmful solution
Frontiers in Oncology 12:1055113 (January 2023) DOI:10.3389/fonc.2022.1055113
Kattan J, Temraz S, Nasr F, Tfayli A, Khater C, Mugharbel A, Ghanem H, Kourie H,
Hachem G, Masri S, Debs J, Shamseddine A.
Management Practices of Locally Advanced and Metastatic Urothelial Carcinoma A
Questionnaire Based Survey among Lebanese Oncologists.
Open Journal of Urology, 2024, 14, 138-149 DOI: 10.4236/oju.2024.142014